Page last updated: 2024-10-25

deferoxamine and Phagocyte Bactericidal Dysfunction

deferoxamine has been researched along with Phagocyte Bactericidal Dysfunction in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Phagocyte Bactericidal Dysfunction: Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantinieaux, B1
Hariga, C1
Ferster, A1
Toppet, M1
Fondu, P1

Other Studies

1 other study available for deferoxamine and Phagocyte Bactericidal Dysfunction

ArticleYear
Desferrioxamine improves neutrophil phagocytosis in thalassemia major.
    American journal of hematology, 1990, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Child; Child, Preschool; Deferoxamine; Female; Humans; Male; Neutrophils; Phagocy

1990